Sirada Wichitaphornkun / Shutterstock.com
Bayer and two Boston hospitals have joined forces in a chronic lung disease research product, with the trio championing the ‘joint lab’ model as a blueprint for pharmaceutical research.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Joint lab, COPD, lung disease, Bayer, Brigham and Women’s Hospital, Massachusetts General Hospital, Joerg Moeller